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Multivariate Pattern Analysis Using the
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Kristin A. Linn, Bilwaj Gaonkar, Jimit Doshi, Christos Davatzikos, and Russell
T. Shinohara

Abstract

Normalization of feature vector values is a common practice in machine learning. Generally, each feature value is standardized to the unit hypercube or by
normalizing to zero mean and unit variance. Classification decisions based on
support vector machines (SVMs) or by other methods are sensitive to the specific
normalization used on the features. In the context of multivariate pattern analysis
using neuroimaging data, standardization effectively up- and down-weights features based on their individual variability. Since the standard approach uses the
entire data set to guide the normalization it utilizes the total variability of these
features. This total variation is inevitably dependent on the amount of marginal
separation between groups. Thus, such a normalization may attenuate the separability of the data in high dimensional space. In this work we propose an alternate
approach that uses an estimate of the control-group standard deviation to normalize features before training. We also show that control-based normalization
provides better interpretation with respect to the estimated multivariate disease
pattern and improves the classifier performance in many cases.
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Abstract
Normalization of feature vector values is a common practice in machine learning.
Generally, each feature value is standardized to the unit hypercube or by normalizing to zero mean and unit variance. Classification decisions based on support vector
machines (SVMs) or by other methods are sensitive to the specific normalization used
on the features. In the context of multivariate pattern analysis using neuroimaging
data, standardization effectively up- and down-weights features based on their individual variability. Since the standard approach uses the entire data set to guide the
normalization it utilizes the total variability of these features. This total variation is
inevitably dependent on the amount of marginal separation between groups. Thus,
such a normalization may attenuate the separability of the data in high dimensional
space. In this work we propose an alternate approach that uses an estimate of the
control-group standard deviation to normalize features before training. We also show
that control-based normalization provides better interpretation with respect to the estimated multivariate disease pattern and improves the classifier performance in many
cases.

1

Introduction

Machine learning classification algorithms such as the support vector machine (SVM) [4, 43]
are often used to map high-dimensional neuroimaging data to a clinical diagnosis or decision. Structural and functional magnetic resonance imaging (MRI) are promising tools for
building biomarkers to diagnose, monitor, and treat neurological and psychological illnesses.
Mass-univariate methods such as statistical parametric mapping [18–20] and voxel-based
morphometry [1, 10] test for marginal disease effects at each voxel, ignoring complex spatial correlations and multivariate relationships among voxels. As a result, methods have
emerged for performing multivariate pattern analysis (MVPA) that leverage the information
contained in the covariance structure of the images to discriminate between the groups being
studied [6, 7, 9, 11–14, 17, 21, 25–27, 29, 31, 36, 38–40, 44, 45, 47, 49]. Identifying multivariate structural and functional signatures in the brain that discriminate between groups
may lead to a better understanding of disease processes and is therefore of great interest in
the field of neuroimaging research.
The SVM is a common choice for estimating multivariate patterns in the brain because it
is amenable to high-dimensional, low sample size data. Our focus in this work is on patterns
in the brain that reflect structural changes due to disease. However, the methods apply
more generally to applications of MVPA to BOLD measurements from fMRI or measures
1
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of connectivity across the brain. The SVM takes as input image-label pairs and returns a
decision function that is a weighted sum of the imaging features. The estimated weights
reflect the joint contribution of the imaging features to the predicted class label.
Machine learning methods in general, and SVMs in particular, are sensitive to differences
in feature scales. For example, a SVM will place more importance on a feature that takes
values in the range of [1000, 2000] than a feature that takes values in the interval [1, 2]. This
is because the former tends to have a stronger influence on distances in high-dimensional
space. To give all voxels or regions of interest equal importance during classifier training,
it is common practice to implement feature-wise standardization in some way, either by
normalizing each to have mean zero and unit variance or by scaling to a common domain.
For example, Peng et al. [34] scale each feature to be in the interval [0, 1], and Etzel et al.
[16], Hanke et al. [23], Wang et al. [46], Zacharaki et al. [50] and Sato et al. [41] normalize
to mean zero and unit variance. Such a preprocessing step, while common in practice, tends
to be applied without weighing the consequent ramifications in a careful manner. Careful
consideration must be given to the choice of feature normalization, as it is directly tied
to the relative magnitude of the estimated SVM weights and thus the performance and
interpretation of the classifier. While the original idea of feature scaling dates back to the
universal approximation theorem from the neural network literature, it has not been explored
in detail in the context of neuroimaging and MVPA. This is the object of this manuscript.
The rest of this paper is organized as follows: in Section 2, we provide a brief introduction
to MVPA using the SVM. In Section 3, we review two popular feature normalization methods
and propose an alternative based on the control-group variability. Using simulations, we
compare the performance of different feature normalization techniques in Section 4. In
Section 5, we investigate the effects of feature normalization by analyzing data from healthy
controls and patients with Alzheimer’s disease. We conclude with a discussion in Section 6.

2

Multivariate Pattern Analysis using the SVM

Let (Yi , X Ti )T , i = 1, . . . , n, denote n independent and identically distributed observations
of the random vector (Y, X T )T , where Y ∈ {−1, 1} denotes the group label, and X ∈ Rp
denotes a vectorized image with p voxels. A popular MVPA tool used in the neuroimaging
community is the SVM [4, 43]. SVMs are known to work well for high dimension, low
sample size data [42]. Such data are common in the neuroimaging-based diagnostic setting.
Henceforth, we focus on MVPA using the SVM.
The hard-margin linear SVM solves the constrained optimization problem
1
arg min ||v||2
v,b 2
such that Yi (v T X i + b) ≥ 1 ∀i = 1, . . . , n,

(1)

where b ∈ R and v ∈ Rp are parameters that describe the classification function. For a given
set of training data, let the solution to (1) be denoted by (ṽ, b̃). Then, for a new observation
2
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X new with unknown label Y new , the classification function c(X new ) = sign(ṽ T X new + b̃)
returns a predicted group label.
When the data from the two groups are not linearly separable, the soft-margin linear
SVM allows some observations to be misclassified during training through the use of slack
variables ξi with associated penalty parameter C. In this case, the optimization problem
becomes
n

X
1
ξi
arg min ||v||2 + C
v,b,ξ 2
i=1
such that:
Yi (v T X i + b) ≥ 1 − ξi ∀i = 1, . . . , n,
ξi ≥ 0 ∀i = 1, . . . , n,

(2)

where C ∈ R is a tuning parameter that penalizes misclassification, and ξ = (ξ1 , ξ2 , . . . , ξn )T
is the vector of slack variables. For details about solving optimization problems (1) and (2)
we refer the reader to Hastie et al. [24].
In high-dimensional problems where the number of features is greater than the number
of observations, the data are almost always separable by a linear hyperplane [32]. Thus,
MVPA is often applied using the hard-margin linear SVM in (1). Select examples include
classification of multiple sclerosis patients into disease subgroups [2], the study of Alzheimer’s
disease [7, 9], and various classification tasks involving patients with depression [5, 22, 28].
This is only a small subset of the relavant literature, which demonstrates the widespread
popularity of the approach.

3

SVM Feature Normalization for MVPA

The choice of feature normalization affects the estimated weight pattern of a SVM and can
lead to vastly different conclusions about the underlying disease process. Two widely implemented approaches are to (i) normalize each feature to have mean zero and unit variance,
and (ii) scale each feature to have a common domain such as [0, 1]. Henceforth, we will refer
to (i) as standard normalization and (ii) as domain standardization [33].
th
Let µj and σj denote the mean and standard deviation of the
Pnj feature, j = 1, . . . , p.
−1
bj = {(n −
Denote
i=1 Xi,j and σ
P the corresponding empirical estimates by X j = n
1)−1 ni=1 (Xi,j − X j )2 }1/2 . Then, subject i’s standard-normalized j th feature is calculated as
Z
Xi,j
=

Xi,j − X j
.
σ
bj

Alternatively, subject i’s domain-scaled j th feature is calculated as
U
Xi,j
=

Xi,j − mini Xi,j
.
maxi Xi,j − mini Xi,j
3
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One potential drawback of using domain scaling is the instability of the minimum and maximum order statistics, especially in small sample sizes. This may introduce bias in the estimated weight pattern by up- and down-weighting features in an unstable way. In comparison,
the standard normalization may seem relatively stable. However, it implicitly depends on
the relative sample size of each group and the separability between groups. To see this, let
fXj denote the marginal distribution of Xj , with mean µj and variance σj2 . Let fXj | Y = y
2
denote the conditional distribution of Xj given Y = y with mean µj,y and variance σj,y
. In
addition, let γ = pr(Y = 1). Then, µj = γµj,1 + (1 − γ)µj,−1 and
σj2 = E(Xj − µj )2
= EXj2 − µ2j
Z
=
x2j {γfXj | Y

= 1 (x)

+ (1 − γ)fXj | Y

= −1 (x)}dx

− µ2j

2
2
+ µ2j,−1 ) − µ2j .
+ µ2j,1 ) + (1 − γ)(σj,−1
= γ(σj,1

After simplification, the previous expression can be written as
2
2
σj2 = γσj,1
+ (1 − γ)σj,−1
+ γ(1 − γ)(µj,1 − µj,−1 )2

(3)

The right-hand side of expression (3) shows that the variance of feature j depends on a
mixture of the conditional variances of both classes and a term that depends on the squared
distance between their marginal means. Larger marginal separability of feature j will lead to
a larger estimate of the pooled standard deviation used for normalization. Thus, normalizing
by the pooled standard deviation can in some cases harshly penalize, or down-weight, features
that have good separability, leading to a loss in predictive performance. We demonstrate
this using simulated data examples in Section 4.
The right-hand side of equation (3) also illuminates how normalization is dependent on
the relative within-group sample sizes, which may have adverse effects on classifier performance. Suppose data for MVPA are available from a case-control study where the cases have
been oversampled. That is, there is one healthy control for each subject with the disease.
Suppose further that the true disease prevalence in the population is rare. Then, the esti2
2
and σj,−1
, whereas the true
mate of σj2 will be an equal mixture of the group variances σj,1
2
2
σj in the population depends more heavily on the control-group variance, σj,−1
. Methods
for dataset or covariate shift address this issue by weighting individual data points to reflect
the distribution of covariates in the population [30, 37]. However, these methods are usually
implemented after feature normalization. As a result, the estimated decision rule may be
undesirably influenced by the use of a biased estimate of the pooled variance.
As an alternative, we propose normalizing the j th feature as follows:
C
Xi,j
=

Xi,j − X j
,
σ
bjC

bjC is the
for all subjects i = 1, . . . , n, where X j is the pooled sample mean of feature j, and σ
sample standard deviation of the j th feature calculated using the control-group data only.
4
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Note that X j and σ
bjC are computed using only the control-group, but the normalization
is applied to subjects from both groups. We refer to this as control normalization. Note
that for features that contribute greatly to the separability of the groups, the control-group
standard deviation will be smaller than the pooled-group standard deviation. Scaling by this
smaller value will implicitly up-weight the most discriminative features in comparison to the
standard-normalization. In some studies or applications, there may not be a control group.
In this case, a reference group may be chosen based on expert knowledge or the scientific
goals of the study. In Section 4 we demonstrate how the choice of feature normalization
technique may lead to a tradeoff of classifier properties such as sensitivity and specificity.
Figure 1 displays an example of the influence of feature normalization on the estimated
SVM weight pattern. We generated n0 = 50 independent control-group observations and
Original Features

Control Normalization

Standard Normalization

Domain Scaling

4
2
labels

0

X2

Control
−2

Disease

−4
−6
−5.0

−2.5

0.0

2.5

5.0 −5.0

−2.5

0.0

2.5

5.0 −5.0

−2.5

0.0

2.5

5.0 −5.0

−2.5

0.0

2.5

5.0

X1

Figure 1: Influence of feature normalization on the SVM decision boundary. From left
to right: original feature scales, control-normalized features, standard-normalized features,
domain-scaled features.
n1 = 50 disease-group observation from models (6) and (7), respectively, defined in Section 4.
All features are independent noise features except the first two, X1 and X2 , which are plotted
pre-normalization in the first panel of Figure 1. The correlation between X1 and X2 in the
control group is ρ0 = −0.2, and it is ρ1 = −0.6 in the disease-group. The control-normalized,
standard-normalized, and domain-scaled versions are plotted in the second, third, and fourth
panels. The estimated SVM decision boundary is projected onto the space of these two
features and is given by the black line in each panel. We carefully chose these parameters
because they represent a scenario where the choice of feature normalization changed the
sign of the estimated optimal SVM line. While the difference in results may not always be
so drastic, this example motivates the need for researchers to adopt a single, interpretable
technique for feature normalization when performing multivariate pattern analysis using
SVMs. We study the effects of feature normalization for a range of parameter settings in
Section 4.
Another advantage of the control normalization is the resulting interpretability of the
feature values. Fixing all other SVM features at a constant value, the estimated weight
5
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corresponding to feature j conveys the magnitude and direction of change in the decision
function score for a one unit increase in feature j, where the units are in terms of the
control-group standard deviation of that feature. In many studies, it is likely that more
knowledge exists about the distribution of values in the normal population, as the disease
being studied may be highly heterogeneous, rare, or not yet well-understood. Being able
to interpret the estimated disease pattern relative to the healthy control distribution may
improve the reproducibility and clinical value of the MVPA results.

Disease−group sample size

4

Simulations
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Figure 2: Average difference in performance measures between the control normalization and
standard normalization for a range of sample sizes. Data generated from models 4 and 5.
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Figure 3: Average difference in performance measures between the control normalization and
domain scaling for a range of sample sizes. Data generated from models 4 and 5.

In this section, we study a range of data-generating models to compare the performance
of the control normalization, standard normalization, and domain scaling when using the
linear SVM for MVPA. For all simulations, we generate p features, (X1 , X2 , . . . , Xp )T , the
first two of which have varying levels of joint discriminative power. The remaining p − 2
6
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are independent noise features. The first two features are generated as mixtures of multivariate normal distributions. The following steps describe the procedure used to obtain the
results in Figures 2–5. For each of M =1,000 iterations, n0 control subjects are generated as
independent draws from the model
 0 
  

X1
0
1 ρ0
∼ Normal
,
,
Xj0 ∼ Normal(0, 1), j = 3, . . . , p. (4)
X20
0
ρ0 1
Non-control group subjects are generated as n1 independent draws from the model
 1 

 

X1
−1
1 ρ1
∼ Normal
,
,
Xj1 ∼ Normal(0, 1), j = 3, . . . , p, (5)
X21
−1
ρ1 1

Disease−group correlation

where Xj0 , Xj1 , j = 3, . . . , p, are all mutually independent. Additionally, we generate t0 = 500
independent control-group samples from model (4) and t1 = 500 independent samples from
model (5) for testing. We then train an SVM using the n0 + n1 training samples using the
scikit learn library in Python, which internally calls libSVM [3]. When n0 6= n1 , we train
a class-weighted SVM that weights the cost parameter by (n1 + n0 )/n0 for the control group
and by (n1 + n0 )/n1 for the disease group. In Figures 2 and 3 the correlations are fixed at
ρ0 = 0, ρ1 = 0, and we vary n0 , n1 ∈ {20, 40, . . . , 200}. In Figures 4 and 5 the sample sizes
are fixed at n0 = 50, n1 = 50, and we vary ρ0 , ρ1 ∈ {−0.9, −0.8, . . . , 0.9}.
We compare the average difference in accuracy, area under the ROC curve (AUC), sensitivity, and specificity of the SVM on the test set. Given the true test labels, accuracy is
defined as the percentage of correct classifications using the SVM decision rule learned from
the training data. Sensitivity is the percentage of correct positive predictions, and specificity
is the percentage of correct negative predictions. The ROC curve is the proportion of true
positives as a function of the false positive rate which ranges in [0, 1] as the SVM intercept
b is varied across the real line. Larger values of the criteria are desirable and indicate better
classifier performance.
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Figure 4: Average difference in performance measures between the control normalization and
standard normalization for a range of feature correlations. Data generated from models 4
and 5.
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Figure 5: Average difference in performance measures between the control normalization and
domain scaling for a range of feature correlations. Data generated from models 4 and 5.
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Figure 6: Average difference in performance measures between the control normalization and
standard normalization for a range of sample sizes. Data generated from models 6 and 7.

Each colored square in the heatmaps represents a self-contained simulation with 1,000
iterations. The color indicates the average difference between a given performance measure
between the control-normalized SVM and either the standard-normalized or domain-scaled
SVM. Dark blue indicates superior performance of the control normalization. Across the
simulations summarized in Figures 2 and 3, average accuracies ranged from approximately
60%–80%, average AUCs ranged from approximately 70%-80%, average sensitivities ranged
from approximately 55%-80%, and average specificities ranged from approximately 55%80%. In Figures 2 and 3, the control normalization performs better on average than the
standard normalization and domain scaling for most combinations of within-group sample
size. Notable exceptions are when the sample size of the control-group is much smaller than
that of the disease-group. The standard normalization appears to improve sensitivity when
the disease-group sample size is large but seemingly at the cost of reduced specificity. Overall,
the results appear similar when comparing the control normalization to domain scaling.
Next, we present a case where the control normalization demonstrates significant improvement over the alternative feature standardizations. The following procedure was used
to obtain the results in Figures 6–7. For each of M =1,000 iterations, n0 control subjects are
8
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Disease−group sample size
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Figure 7: Average difference in performance measures between the control normalization and
domain scaling for a range of sample sizes. Data generated from models 6 and 7.

generated as independent draws from the model

 

 0 
2
1 ρ0
X1
∼ Normal
,
,
X20
−2
ρ0 1

Xj0 ∼ Normal(0, 1), j = 3, . . . , p. (6)

Non-control group subjects are generated as n1 independent draws from the model
 1 

 

X1
−1
5 ρ1
∼ Normal
,
,
Xj1 ∼ Normal(0, 1), j = 3, . . . , p. (7)
X21
−1
ρ1 5
Additionally, we generate t0 = 500 independent control-group samples from model (6) and
t1 = 500 independent samples from model (7) for testing. We vary the within-group correlation parameters, ρ0 , ρ1 ∈ {−0.9, −0.8, . . . , 0.9}. For this set of model parameters, the
control-normalization demonstrates greater than three percent improvement in accuracy,
AUC, and specificity for a variety of sample sizes when compared to the standard normalization and domain scaling. In some cases, the gains in specificity are due to lower sensitivity.
However, the overall accuracy and AUC in these cases are still improved.

5

Case Study

The Alzheimer’s Disease Neuroimaging Initiative (ADNI) (http://www.adni.loni.usc.edu) is
a multi-million dollar study funded by a number of public and private resources from the
National Institute on Aging (NIA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), Food and Drug Administration (FDA), the pharmaceutical industry,
and non-profit organizations. Aims of the study include developing sensitive and specific
image-based biomarkers for early diagnosis of Alzheimer’s disease (AD), as well as monitoring the progression of mild cognitive impairment (MCI) and AD. Understanding and
predicting disease trajectories is imperative for the discovery of effective treatments that
intervene in the early stages of the disease to prevent irreversible damage to the brain.
The ADNI data are publicly available and as a result have been thoroughly analyzed in
the neuroimaging literature [48]. A detailed comparison of SVM classification results using
9
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Figure 8: Density plots of ROI volumes by group.

different categories of imaging features is given in Cuingnet et al. [7]. In this section, we
compare the performance of different SVM feature normalization techniques using volumes
obtained from a multi-atlas segmentation pipeline applied to structural MRIs from the ADNI
database [15].
The final dataset used for this analysis consists of labels indicating the presence or absence
of AD and the volumes of 137 regions of interest (ROIs) in the brain for each subject.
Each region is divided by the subject’s total intracranial volume to adjust for differences
in individual brain size. The data consist of 230 healthy controls (CN) and 200 patients
diagnosed with AD with ages ranging between 55 and 90. AD is associated with atrophy
in the brain, and thus the AD group has smaller volumes on average in particular ROIs
compared to the CN group.
To give intuition about the differences between the control and standard normalization
procedures in the ADNI data, we plot the densities of six features, stratified by group, in
Figure 8. Whereas the pooled and control-group estimated variability is nearly identical
for features such as the white matter parietal lobe and occipital pole, the control-group
variability is less than the pooled variability for more marginally separable features such as
the amygdala, hippocampus, inferior lateral ventricle, and parahippocampal gyrus. Thus, we
expect a SVM trained after control normalization to place relatively heavier weights on these
marginally discriminative features than a SVM trained after standard normalization. Figure
9 displays SVM weight patterns from the three methods. Based on Figure 9, it appears all
methods obtain similar estimated disease patterns with a few subtle differences. Table 1 lists
the top 10 features in order of the magnitude of their weights. As anticipated, the control
normalization places more emphasis on the two amygdala regions because their marginal
separability ensures a smaller denominator is used in the control-group normalization step,
10
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Figure 9: SVM weight patterns for discriminating between AD and CN subjects by feature
standardization method.

up-weighting these features compared to the standard normalization.
Rank
1
2
3
4
5
6
7
8
9
10

Control Normalization
Left Hippocampus
Right Hippocampus
Left Inferior Lateral Ventricle
Left Inferior Temporal Gyrus
Left Amygdala
Right Amygdala
Right Middle Temporal Gyrus
Left Middle Frontal Gyrus
Right Angular Gyrus
Right Inferior Lateral Ventricle

Standard Normalization
Left Hippocampus
Left Inferior Temporal Gyrus
Left Inferior Lateral Ventricle
Left Middle Frontal Gyrus
Right Hippocampus
Left Superior Frontal Gyrus
Right Middle Temporal Gyrus
Left Amygdala
Left Superior Temporal Gyrus
Right Calcarine Cortex

Domain Scaling
Left Hippocampus
Right Hippocampus
Left Inferior Lateral Ventricle
Left Inferior Temporal Gyrus
Left Middle Frontal Gyrus
Right Middle Temporal Gyrus
Left Superior Temporal Gyrus
Right Amygdala
Left Amygdala
Left Middle Temporal Gyrus

Table 1: Top 10 ranked features by the SVM weights in decreasing absolute value.

We compare the control normalization proposed in Section 3 to the standard normalization and domain scaling. Table 2 displays 5-fold cross-validated estimates of classifier
accuracy, area under the curve (AUC), sensitivity, and specificity. The control normalization and domain scaling outperform the standard normalization across all performance
measures, increasing the cross-validated accuracy, sensitivity, and specificity by more than
one percent. By a small margin, domain-scaling performs best in terms of prediction for this
dataset but at the cost of fitted model interpretability. To quantify the uncertainty in the
estimates in Table 2, we repeated the 5-fold cross-validation proceedure 1000 times using
random subsamples of 140 patients and 140 controls. The point estimates are shown with a
single standard error on each side in Figure 10. For this particular data set, the performance
differences are not statistically significant across the three methods.
11
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Method Accuracy AUC Sensitivity Specificity
Control Normalization
88%
94%
84%
93%
89%
94%
85%
93%
Domain Scaling
Standard Normalization
87%
94%
82%
91%
Table 2: 5-fold cross-validation results.
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Figure 10: 5-fold cross-validation results with measures of uncertainty estimated by subsampling the original data.

6

Discussion

The roots of feature scaling for preprocessing lie in the neural network literature of the 1990s.
The universal approximation theorem, which broadly states that simple neural networks
can approximate a rich set of functions, was initially proven for functions defined on a
unit hypercube domain using a multilayer perceptron constructed with sigmoidal neurons
[8]. It became natural to assume that centering and scaling of data would lead to a faster
convergence even though neural networks are theoretically affine invariant [35]. For the most
part, the optimization turned out to be more graceful with these scaled inputs, since it slowed
down network saturation and avoided the vanishing gradients problem to a certain extent.
However, applying scaling to kernel methods such as SVMs or distance-based methods
such as k-means tends to yield completely different results depending on the scaling method
used. This is because these methods are not transformation-invariant. In such a case, scaling
essentially imposes a form of soft feature selection since it implicitly changes the metric used
for computing the kernel matrix. This fact is important in the context of image-based
diagnosis using SVMs with region of interest (ROI) data. Scaling implicitly enforces the fact
that variation in the amygdala, which is a relatively small structure in terms of volume, is as
important as that in the prefrontal lobe, which is much larger in volume. Thus, appropriate
scaling of features is an important but under-emphasized issue that we have attempted to
call attention to in this manuscript.
It is critical for researchers wishing to interpret the results of MVPA from SVMs to
12
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understand how the choice of feature normalization influences the results, as well as how
to determine the best method for their scientific question. We have proposed a controlbased normalization and demonstrated several advantages of the approach. Most notably,
we have highlighted the possibility of improved classifier performance according to criteria
such as accuracy and AUC for a comprehensive set of data generating distributions. The control normalization improves classifier performance by giving higher weight, relative to other
standardization techniques, to features with greater marginal separability between groups.
Depending on the underlying data generating distribution and relative sample size between
groups, different classifiers will experience tradeoffs between sensitivity and specificity. The
optimal choice of feature normalization may depend on the unknown data generating distribution as well as certain clinical considerations. As a result, the interpretability of the control
normalization is an attractive property that makes it amenable to a vast majority of clinical
applications. Given the overall increase in AUC demonstrated by the control normalization
in the simulations, it is possible that simply shifting the estimated optimal hyperplane would
lead to a classifier that has the same sensitivity as the standard-normalized hyperplane but
with increased specificity.
Interpretability of estimated disease patterns is a desirable quality for most applications
of MVPA to neuroimaging data. Standardizing features by the control-group variability
improves interpretability over other feature normalization methods. We showed in Section 3 that the standard normalization method depends on the relative sample size of the
two groups as well as the marginal separability; in contrast, the control normalization is
unaffected by these qualities of the data and hence provides better generalizability across
samples. We believe that including a control normalization step in the MVPA preprocessing
pipeline is a simple alternative to current practice that promises increased interpretability,
generalizability, and performance of the results.
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[2] Bendfeldt, K., Klöppel, S., Nichols, T. E., Smieskova, R., Kuster, P., Traud, S., MuellerLenke, N., Naegelin, Y., Kappos, L., Radue, E.-W., et al. (2012). Multivariate pattern
classification of gray matter pathology in multiple sclerosis. Neuroimage, 60(1):400–408.
[3] Chang, C.-C. and Lin, C.-J. (2011). LIBSVM: A library for support vector machines.
ACM Transactions on Intelligent Systems and Technology, 2:27:1–27:27.
[4] Cortes, C. and Vapnik, V. (1995). Support-vector networks. Machine learning, 20(3):273–
297.
[5] Costafreda, S. G., Chu, C., Ashburner, J., and Fu, C. H. (2009). Prognostic and diagnostic potential of the structural neuroanatomy of depression. PLoS One, 4(7):e6353.
[6] Craddock, R. C., Holtzheimer, P. E., Hu, X. P., and Mayberg, H. S. (2009). Disease state
prediction from resting state functional connectivity. Magnetic Resonance in Medicine,
62(6):1619–1628.
[7] Cuingnet, R., Rosso, C., Chupin, M., Lehricy, S., Dormont, D., Benali, H., Samson, Y.,
and Colliot, O. (2011). Spatial regularization of {SVM} for the detection of diffusion
alterations associated with stroke outcome. Medical Image Analysis, 15(5):729 – 737.
Special Issue on the 2010 Conference on Medical Image Computing and Computer-Assisted
Intervention.
[8] Cybenko, G. (1989). Approximation by superpositions of a sigmoidal function. Mathematics of control, signals and systems, 2(4):303–314.
[9] Davatzikos, C., Bhatt, P., Shaw, L. M., Batmanghelich, K. N., and Trojanowski, J. Q.
(2011). Prediction of {MCI} to {AD} conversion, via mri, {CSF} biomarkers, and pattern
classification. Neurobiology of Aging, 32(12):2322.e19 – 2322.e27.
[10] Davatzikos, C., Genc, A., Xu, D., and Resnick, S. M. (2001). Voxel-based morphometry
using the {RAVENS} maps: Methods and validation using simulated longitudinal atrophy.
NeuroImage, 14(6):1361 – 1369.
[11] Davatzikos, C., Resnick, S., Wu, X., Parmpi, P., and Clark, C. (2008). Individual patient diagnosis of {AD} and {FTD} via high-dimensional pattern classification of {MRI}.
NeuroImage, 41(4):1220 – 1227.
[12] Davatzikos, C., Ruparel, K., Fan, Y., Shen, D., Acharyya, M., Loughead, J., Gur, R.,
and Langleben, D. D. (2005). Classifying spatial patterns of brain activity with machine
learning methods: application to lie detection. Neuroimage, 28(3):663–668.
14

http://biostats.bepress.com/upennbiostat/art42

[13] Davatzikos, C., Xu, F., An, Y., Fan, Y., and Resnick, S. M. (2009). Longitudinal
progression of alzheimer’s-like patterns of atrophy in normal older adults: the spare-ad
index. Brain, 132(8):2026–2035.
[14] De Martino, F., Valente, G., Staeren, N., Ashburner, J., Goebel, R., and Formisano, E.
(2008). Combining multivariate voxel selection and support vector machines for mapping
and classification of fmri spatial patterns. Neuroimage, 43(1):44–58.
[15] Doshi, J., Erus, G., Ou, Y., and Davatzikos, C. (2013). Ensemble-based medical image labeling via sampling morphological appearance manifolds. In MICCAI Challenge
Workshop on Segmentation: Algorithms, Theory and Applications. Nagoya, Japan.
[16] Etzel, J. A., Valchev, N., and Keysers, C. (2011). The impact of certain methodological
choices on multivariate analysis of fmri data with support vector machines. Neuroimage,
54(2):1159–1167.
[17] Fan, Y., Shen, D., Gur, R. C., Gur, R. E., and Davatzikos, C. (2007). Compare:
classification of morphological patterns using adaptive regional elements. Medical Imaging,
IEEE Transactions on, 26(1):93–105.
[18] Frackowiak, R., Friston, K., Frith, C., Dolan, R., and Mazziotta, J., editors (1997).
Human Brain Function. Academic Press USA.
[19] Friston, K. J., Frith, C., Liddle, P., and Frackowiak, R. (1991). Comparing functional
(pet) images: the assessment of significant change. Journal of Cerebral Blood Flow &
Metabolism, 11(4):690–699.
[20] Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J.-P., Frith, C. D., and Frackowiak,
R. S. (1994). Statistical parametric maps in functional imaging: a general linear approach.
Human brain mapping, 2(4):189–210.
[21] Gaonkar, B. and Davatzikos, C. (2013). Analytic estimation of statistical significance
maps for support vector machine based multi-variate image analysis and classification.
NeuroImage, 78(0):270 – 283.
[22] Gong, Q., Wu, Q., Scarpazza, C., Lui, S., Jia, Z., Marquand, A., Huang, X., McGuire,
P., and Mechelli, A. (2011). Prognostic prediction of therapeutic response in depression
using high-field mr imaging. Neuroimage, 55(4):1497–1503.
[23] Hanke, M., Halchenko, Y. O., Sederberg, P. B., Olivetti, E., Fründ, I., Rieger, J. W.,
Herrmann, C. S., Haxby, J. V., Hanson, S. J., and Pollmann, S. (2009). Pymvpa: a
unifying approach to the analysis of neuroscientific data. Frontiers in neuroinformatics,
3.
[24] Hastie, T., Tibshirani, R., and Friedman, J. (2001). Springer New York Inc.

15

Hosted by The Berkeley Electronic Press
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